TREVI HEALTH VENTURES

News

portfolioLogo

  1. June 2, 2010

    Ikonisys to Present at the Jefferies 2010 Global Life Sciences Conference

  2. March 25, 2010

    Clinical Laboratory Partners Signs Marketing Agreement with Ikonisys For Proprietary Cervical Cancer Test

  3. March 23, 2010

    Ikonisys Awarded Patent for the Process for Identifying FISH Signals

  4. February 9, 2010

    Ikonisys to Introduce its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference

  5. December 10, 2009

    Enzo Biochem's Clinical Labs Division Signs Exclusive Marketing Agreement With Ikonisys For Proprietary Molecular-Based Cervical Cancer Test

  6. September 2, 2009

    Ikonisys to Present at the Thomas Weisel Partners Healthcare Conference 2009

  7. December 16, 2008

    Ikonisys to Present at the J.P. Morgan 27th Annual Healthcare Conference

  8. October 14, 2008

    Ikonisys Reports Positive Results from Clinical Study Designed to Evaluate the Efficacy of Circulating Tumor Cell Detection with Ikonisys’ Automated Microscope

  9. October 14, 2008

    Ikonisys Reports Positive Results from Clinical Study Designed to Evaluate the Efficacy of Circulating Tumor Cell Detection with Ikonisys’ Automated Microscope

  10. October 7, 2008

    Ikonisys Featured in NY Times

  11. September 23, 2008

    Ikonisys to Present at AdvaMed 2008: The MedTech Conference

  12. September 22, 2008

    Ikonisys Introduces Rare-Cell Test Designed to Determine Early Progression to Cervical Cancer

  13. September 18, 2008

    Ikonisys to Present at UBS Global Life Sciences Conference

  14. June 18, 2008

    Ikonisys Appoints Louise A. Mawhinney, CPA as Senior Vice President and Chief Financial Officer

  15. March 5, 2008

    Ikonisys Receives CMS Registration to Establish Clinical Laboratory for Proprietary, Rare-Cell Based Tests

  16. February 1, 2008

    Ikonisys begins clinical trial for early, non-invasive testing of Down syndrome

  17. October 17, 2007

    Ikonisys closes $30 million Series E financing; investment reflects successful development of rare cell detection testing platform

  18. May 17, 2007

    Ikonisys awarded contract by Michigan Institute of Urology for digital microscopy system and bladder cancer application

  19. January 24, 2007

    Ikonisys receives FDA clearance for automated bladder cancer test

  20. November 6, 2006

    Ikonisys appoints J. Timothy Corcoran to Board of Directors

  21. September 28, 2006

    Ikonisys receives FDA clearance for prenatal testing application

  22. August 1, 2006

    Ikonisys awarded platform contract by Neogenomics Laboratories for automated cell-based diagnosis

  23. March 20, 2006

    Ikonisys names Paul White Chief Financial Officer & VP of Business Development

  24. March 8, 2006

    Ikonisys, inc. raises $10 million in series D financing

  25. February 20, 2006

    Ikonisys gets FDA clearance to market ikoniscope- fastFISH amnio test system to the US market